Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13

Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall

Authors Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P, Shah K

Received 6 July 2020

Accepted for publication 12 August 2020

Published 24 September 2020 Volume 2020:13 Pages 691—700

DOI https://doi.org/10.2147/CCID.S271013

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg


Muhammed Majeed,1– 3 Shaheen Majeed,1– 3 Kalyanam Nagabhushanam,2 Lakshmi Mundkur,1 Prakriti Neupane,3 Kalpesh Shah3

1Sami Labs Limited, Bangalore, Karnataka 560058, India; 2Sabinsa Corporation, New Jersey, East Windsor 08520, USA; 3ClinWorld Private Limited, Bangalore, Karnataka, India

Correspondence: Kalpesh Shah
ClinWorld Private Limited, 19/1 & 19/2, I Main 2nd Phase, Peenya Industrial Area, Bangalore, Karnataka 560058, India
Tel +918028397973
Email kalpesh@clinworld.org

Background: Hair fall is a widespread problem among all genders, ages, and ethnicity with both physical and psychological effects.
Objective: This clinical study was designed to evaluate the efficacy and safety of a hair serum formulation containing amla extract, freeze-dried coconut water, and the micronutrient selenium along with sandalwood odorant and peanut shell extract in healthy male and female volunteers with hair fall.
Methods: A total of 42 subjects were enrolled and completed the study and they used the test product daily for 90 days. TrichoScan® was used to evaluate the efficacy of the test product for improving hair growth rate, hair density, anagen hair, telogen hair, and the density of vellus and terminal hair. Hair thinning and hair fall reduction were compared to its basline by both dermatologists and subject self-assessment questionnaires.
Result and Discussion: After 90 days of test product application, there was a significant improvement in hair growth rate (< 0.0001), hair density (< 0.0001), vellus hair density (< 0.0001), and terminal hair density (< 0.0001) in comparison to baseline. There was a significant reduction in hair fall with bulb (< 0.0001) and without bulb (< 0.0001), and hair thinning (< 0.0001) compared to the baseline measurement. Adverse events were not recorded during the study. No skin intolerance was reported during the study, and the test product was considered dermatologically safe to use.

Keywords: anti-hair fall serum, hair growth, TrichoScan®, hair follicles, Saberry®, Cococin®, PeptiSeLect®, sandalwood odorant, Cosmoperine®

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]